Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lanfranco Pellesi

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Drug, Healthcare and Patient Safety|December 1, 2021
Safety and Risk of Medication Overuse Headache in Lasmiditan and Second-Generation Gepants: A Rapid ReviewFlavia Lo Castro, Simona Guerzoni, Lanfranco Pellesi
Clinical Pharmacology in Drug Development|April 15, 2017
Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to DateLanfranco Pellesi, Simona Guerzoni, Luigi Alberto Pini
Frontiers in Immunology|February 6, 2026
Mapping the immune and epigenetic landscape of medication-overuse headache (MOH): a systematic reviewNanna Elman Andersen, Marta Waliszewska-Prosół, Lanfranco Pellesi
Pain and Therapy|September 19, 2025
Neurotransmitter Imbalance in Cluster Headache: A Systematic Review of Mechanisms and Therapeutic TargetsLanfranco Pellesi, Anas Mohammad, Wei Wang, et al.
Expert Opinion on Drug Discovery|June 10, 2024
The preclinical discovery and development of atogepant for migraine prophylaxisCarlo Baraldi, Dagmar Beier, Paolo Martelletti, et al.
Expert Review of Neurotherapeutics|September 12, 2024
Rimegepant and atogepant: novel drugs providing innovative opportunities in the management of migraineWilliam David Wells-Gatnik, Lanfranco Pellesi, Paolo Martelletti
Pharmacological Research|May 3, 2018
Drug-drug interactions in the treatment for alcohol use disorders: A comprehensive reviewSimona Guerzoni, Lanfranco Pellesi, Luigi Alberto Pini, et al.
Journal of Clinical Medicine|March 25, 2022
Clinical Evidence of Cannabinoids in Migraine: A Narrative ReviewFlavia Lo Castro, Carlo Baraldi, Lanfranco Pellesi, et al.
The Journal of Headache and Pain|May 6, 2016
Increased efficacy of regularly repeated cycles with OnabotulinumtoxinA in MOH patients beyond the first year of treatmentSimona Guerzoni, Lanfranco Pellesi, Carlo Baraldi, et al.
The Journal of Headache and Pain|July 12, 2024
Glucagon-like peptide-1 (GLP-1) receptor agonists for headache and pain disorders: a systematic reviewWael Halloum, Yousef Al Dughem, Dagmar Beier, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Drug, Healthcare and Patient Safety|December 1, 2021
Safety and Risk of Medication Overuse Headache in Lasmiditan and Second-Generation Gepants: A Rapid ReviewFlavia Lo Castro, Simona Guerzoni, Lanfranco Pellesi
Clinical Pharmacology in Drug Development|April 15, 2017
Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to DateLanfranco Pellesi, Simona Guerzoni, Luigi Alberto Pini
Frontiers in Immunology|February 6, 2026
Mapping the immune and epigenetic landscape of medication-overuse headache (MOH): a systematic reviewNanna Elman Andersen, Marta Waliszewska-Prosół, Lanfranco Pellesi
Pain and Therapy|September 19, 2025
Neurotransmitter Imbalance in Cluster Headache: A Systematic Review of Mechanisms and Therapeutic TargetsLanfranco Pellesi, Anas Mohammad, Wei Wang, et al.
Expert Opinion on Drug Discovery|June 10, 2024
The preclinical discovery and development of atogepant for migraine prophylaxisCarlo Baraldi, Dagmar Beier, Paolo Martelletti, et al.
Expert Review of Neurotherapeutics|September 12, 2024
Rimegepant and atogepant: novel drugs providing innovative opportunities in the management of migraineWilliam David Wells-Gatnik, Lanfranco Pellesi, Paolo Martelletti
Pharmacological Research|May 3, 2018
Drug-drug interactions in the treatment for alcohol use disorders: A comprehensive reviewSimona Guerzoni, Lanfranco Pellesi, Luigi Alberto Pini, et al.
Journal of Clinical Medicine|March 25, 2022
Clinical Evidence of Cannabinoids in Migraine: A Narrative ReviewFlavia Lo Castro, Carlo Baraldi, Lanfranco Pellesi, et al.
The Journal of Headache and Pain|May 6, 2016
Increased efficacy of regularly repeated cycles with OnabotulinumtoxinA in MOH patients beyond the first year of treatmentSimona Guerzoni, Lanfranco Pellesi, Carlo Baraldi, et al.
The Journal of Headache and Pain|July 12, 2024
Glucagon-like peptide-1 (GLP-1) receptor agonists for headache and pain disorders: a systematic reviewWael Halloum, Yousef Al Dughem, Dagmar Beier, et al.
Pageof 6